Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer

被引：0
|
作者：
Lashen, A. L. [1 ]
Toss, M. T. [1 ]
Fadhil, W. F. [1 ]
Oni, G. O. [1 ]
Madhusudan, S. M. [1 ]
Rakha, E. R. [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2023年 / 261卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [31] Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore
    Lopes, G. de Lima
    Chien, R.
    Hornberger, J. C.
    BREAST, 2011, 20 : S48 - S48
  • [32] Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland
    Lillian Smyth
    Geoff Watson
    Elaine M. Walsh
    Catherine M. Kelly
    Maccon Keane
    M. John Kennedy
    Liam Grogan
    Bryan T. Hennessy
    Seamus O’Reilly
    Linda E. Coate
    Miriam O’Connor
    Cecily Quinn
    Katharina Verleger
    Olaf Schoeman
    Susan O’Reilly
    Janice M. Walshe
    Breast Cancer Research and Treatment, 2015, 153 : 573 - 582
  • [33] Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
    Salah Fayaz
    Heba El-Sayed Eissa
    Gerges Attia Demian
    Journal of the Egyptian National Cancer Institute, 32
  • [34] Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
    Fayaz, Salah
    Eissa, Heba El-Sayed
    Demian, Gerges Attia
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2020, 32 (01)
  • [35] Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
    Asad, Juhi
    Jacobson, Allyson F.
    Estabrook, Alison
    Smith, Sharon Rosenbaum
    Boolbol, Susan K.
    Feldman, Sheldon M.
    Osborne, Michael P.
    Boachie-Adjei, Kwadwo
    Twardzik, Wendy
    Tartter, Paul I.
    AMERICAN JOURNAL OF SURGERY, 2008, 196 (04): : 527 - 529
  • [36] Practice-changing use of the 21-gene oncotype DX breast recurrence score test in Latin American hospitals.
    Leonidas Gomez, Henry
    Enrique Bargallo-Rocha, Juan
    Jorge Billinghurst, Roberto
    Nunez de Pierro, Anibal Roberto
    Andres Colo, Federico
    Benitez Gil, Lisandro Luis
    Allemand, Carola
    Leonardo McLean, Ignacio
    Lema-Medina, Mauricio
    Herazo-Maya, Fernando
    Jose Terrier, Francisco
    Gerson Cwilich, Raquel
    Leon Rivera, Mauricio
    Gabriela Falcon, Silvia
    Eduardo Castano, Roberto
    Cordeiro Oliveira, Sergio
    Jakubowski, Debbie M.
    Chao, Calvin Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Evaluating utilization characteristics for the Oncotype DX recurrence score in early-stage breast cancer.
    Chen, C.
    Patt, D. A.
    Kazzaz, D. R.
    Shankleton, J.
    Forsyth, M. T.
    Ganesh, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Associations between the 21-gene Oncotype DX Recurrence Score (RS), Ki67, and Race in Early Breast Cancer (EBC) Using the National Cancer Database (NCDB)
    Patel, Rima
    Kwon, Deukwoo
    Van Hyfte, Grace
    Sparano, Joseph
    Tiersten, Amy
    CANCER RESEARCH, 2023, 83 (05)
  • [39] Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor-Positive Breast Cancer
    Kelly, Catherine M.
    Bernard, Philip S.
    Krishnamurthy, Savitri
    Wang, Bailiang
    Ebbert, Mark T. W.
    Bastien, Roy R. L.
    Boucher, Kenneth M.
    Young, Elliana
    Iwamoto, Takayuki
    Pusztai, Lajos
    ONCOLOGIST, 2012, 17 (04): : 492 - 498
  • [40] The Relationship between Oncotype DX Recurrence Score, Clinicopathological Factors, and Molecular Classification in Breast Cancer
    Tang, P.
    Wang, J.
    Hicks, D. G.
    Wang, X.
    Schiffhauer, L.
    Shayne, M.
    Huston, A.
    Skinner, K.
    Griggs, J.
    Lyman, G.
    MODERN PATHOLOGY, 2009, 22 : 72A - 72A
12345